Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients With Myelodysplastic Syndromes.
Phase of Trial: Phase I/II
Latest Information Update: 24 Sep 2018
At a glance
- Drugs Decitabine (Primary) ; Tretinoin (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 13 Sep 2018 Status changed from active, no longer recruiting to suspended.
- 01 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.
- 01 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.